Manuele Martinelli

Manuele Martinelli

Auto-generated profile, based on publicly available information

Manuele Martinelli

Novartis Vaccines and Diagnostics, Siena, Italy

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2009 in Nature Structural & Molecular Biology
Verified
Journal Article
Closed access
PDF file
LBLucia Banci
Lucia Banci
IBIvano Bertini
Ivano Bertini
CCChiara Cefaro
Chiara Cefaro
Simone Ciofi-BaffoniSimone Ciofi-Baffoni
Simone Ciofi-Baffoni
AGAngelo Gallo
Angelo Gallo
KTKostas Tokatlidis
Kostas Tokatlidis

1 November 2004 in Journal of Biological Chemistry
Verified
Journal Article
Open access
Fabio ArnesanoFabio Arnesano
Fabio Arnesano
LBLucia Banci
Lucia Banci
IBIvano Bertini
Ivano Bertini
MMManuele Martinelli
Manuele Martinelli
YFYoshiaki Furukawa
Yoshiaki Furukawa
TOThomas V. O'HAlloran
Thomas V. O'HAlloran
The eukaryotic copper,zinc superoxide dismutases are remarkably stable dimeric proteins that maintain an intrasubunit disulfide bond in the reducing environment of the cytosol and are active under a variety of stringent denaturing conditions. The structural interplay of conserved disulfide bond and metal-site occupancy in human copper,zinc superoxide dismutase (hSOD1) is of increasing interest as these post-translational modifications are known to dramatically alter the catalytic chemistry, the subcellular localization, and the susceptibility of the protein to aggregation. Using biophysical methods, we find no significant change in the gross secondary or tertiary structure of the demetallated form upon reduction of the disulfide. Interestingly, reduction does lead to a dramatic change in the quaternary structure, decreasing the monomer-to-dimer equilibrium constant by at least four orders of magnitude. This reduced form of hSOD1 is monomeric, even at concentrations well above the physiological range. Either the addition of Zn(II) or the formation of the disulfide leads to a shift in equilibrium that favors the dimeric species, even at low protein concentrations (i.e. micromolar range). We conclude that only the most immature form of hSOD1, i.e. one without any post-translational modifications, favors the monomeric state under physiological conditions. This finding provides a basis for understanding the selectivity of mitochondrial SOD1 import and may be relevant to the toxic properties of mutant forms of hSOD1 that can cause the familial form of amyotrophic lateral sclerosis.

3 July 2007 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
LBLucia Banci
Lucia Banci
IBIvano Bertini
Ivano Bertini
ADArmando Durazo
Armando Durazo
SGStefania Girotto
Stefania Girotto
EGEdith Butler Gralla
Edith Butler Gralla
JWJulian P. Whitelegge
Julian P. Whitelegge
Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder selectively affecting motor neurons; 90% of the total cases are sporadic, but 2% are associated with mutations in the gene coding for the antioxidant enzyme copper–zinc superoxide dismutase (SOD1). The causes of motor neuron death in ALS are poorly understood in general, but for SOD1-linked familial ALS, aberrant oligomerization of SOD1 mutant proteins has been strongly implicated. In this work, we show that wild-type human SOD1, when lacking both its metal ions, forms large, stable, soluble protein oligomers with an average molecular mass of ≈650 kDa under physiological conditions, i.e., 37°C, pH 7.0, and 100 μM protein concentration. It further is shown here that intermolecular disulfide bonds are formed during oligomerization and that Cys-6 and Cys-111 are implicated in this bonding. The formation of the soluble oligomers was monitored by their ability to enhance the fluorescence of thioflavin T, a benzothiazole dye that increases in fluorescence intensity upon binding to amyloid fibers, and by disruption of this binding upon addition of the chaotropic agent guanidine hydrochloride. Our results suggest a general, unifying picture of SOD1 aggregation that could operate when wild-type or mutant SOD1 proteins lack their metal ions. Although we cannot exclude other mechanisms in SOD1-linked familial ALS, the one proposed here has the strength of explaining how a large and diverse set of SOD1 mutant proteins all could lead to disease through the same mechanism.

13 May 2008 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
LBLucia Banci
Lucia Banci
IBIvano Bertini
Ivano Bertini
Simone Ciofi-BaffoniSimone Ciofi-Baffoni
Simone Ciofi-Baffoni
THTheodoros Hadjiloi
Theodoros Hadjiloi
MMManuele Martinelli
Manuele Martinelli
PPPeep Palumaa
Peep Palumaa
The human protein Cox17 contains three pairs of cysteines. In the mitochondrial intermembrane space (IMS) it exists in a partially oxidized form with two S–S bonds and two reduced cysteines (HCox17 2S-S ). HCox17 2S-S is involved in copper transfer to the human cochaperones Sco1 and Cox11, which are implicated in the assembly of cytochrome c oxidase. We show here that Cu(I)HCox17 2S-S , i.e., the copper-loaded form of the protein, can transfer simultaneously copper(I) and two electrons to the human cochaperone Sco1 (HSco1) in the oxidized state, i.e., with its metal-binding cysteines forming a disulfide bond. The result is Cu(I)HSco1 and the fully oxidized apoHCox17 3S-S , which can be then reduced by glutathione to apoHCox17 2S-S . The HSco1/HCox17 2S-S redox reaction is thermodynamically driven by copper transfer. These reactions may occur in vivo because HSco1 can be found in the partially oxidized state within the IMS, consistent with the variable redox properties of the latter compartment. The electron transfer-coupled metallation of HSco1 can be a mechanism within the IMS for an efficient specific transfer of the metal to proteins, where metal-binding thiols are oxidized. The same reaction of copper–electron-coupled transfer does not occur with the human homolog of Sco1, HSco2, for kinetic reasons that may be ascribed to the lack of a specific metal-bridged protein–protein complex, which is instead observed in the Cu(I)HCox17 2S-S /HSco1 interaction.

1 February 2010 in Antimicrobial Agents and Chemotherapy
Verified
Journal Article
Closed access
FGFrancesco Giuliani
Francesco Giuliani
MMManuele Martinelli
Manuele Martinelli
ACAnnalisa Cocchi
Annalisa Cocchi
DADebora Arbia
Debora Arbia
LFLia Fantetti
Lia Fantetti
GRGabrio Roncucci
Gabrio Roncucci
Resistance to antimicrobial agents is emerging in a wide variety of nosocomial and community-acquired pathogens. The development of alternative therapies against nosocomial infections caused by clinically relevant pathogens represents a major public health concern. RLP068/Cl is a novel Zn(II) phthalocyanine proposed as a photosensitizer suitable for antimicrobial photodynamic therapy (APDT) for localized infections. Its ability, following activation by light, to induce resistance in three major human pathogens after 20 daily passages was studied. Simultaneously for the same strains, the ability of daily sequential subcultures in subinhibitory concentrations of RLP068/Cl to develop resistant mutants without illumination was evaluated. We demonstrate that 20 consecutive APDT treatments with RLP068/Cl did not result in any resistant mutants and that, in dark conditions, only Staphylococcus aureus strains had increased MICs of RLP068/Cl. However, even in this case, the susceptibility of the mutated bacteria to APDT was not affected by their MIC increase.

27 February 2008 in PLOS ONE
Verified
Journal Article
Open access
PDF file
LBLucia Banci
Lucia Banci
IBIvano Bertini
Ivano Bertini
MBMirela Boca
Mirela Boca
SGStefania Girotto
Stefania Girotto
MMManuele Martinelli
Manuele Martinelli
MVMiguela Vieru
Miguela Vieru
There are about 100 single point mutations of copper, zinc superoxide dismutase 1 (SOD1) which are reported (http://alsod.iop.kcl.ac.uk/Als/index.aspx) to be related to the familial form (fALS) of amyotrophic lateral sclerosis (ALS). These mutations are spread all over the protein. It is well documented that fALS produces protein aggregates in the motor neurons of fALS patients, which have been found to be associated to mitochondria. We selected eleven SOD1 mutants, most of them reported as pathological, and characterized them investigating their propensity to aggregation using different techniques, from circular dichroism spectra to ThT-binding fluorescence, size-exclusion chromatography and light scattering spectroscopy. We show here that these eleven SOD1 mutants, only when they are in the metal-free form, undergo the same general mechanism of oligomerization as found for the WT metal-free protein. The rates of oligomerization are different but eventually they give rise to the same type of soluble oligomeric species. These oligomers are formed through oxidation of the two free cysteines of SOD1 (6 and 111) and stabilized by hydrogen bonds, between beta strands, thus forming amyloid-like structures. SOD1 enters the mitochondria as demetallated and mitochondria are loci where oxidative stress may easily occur. The soluble oligomeric species, formed by the apo form of both WT SOD1 and its mutants through an oxidative process, might represent the precursor toxic species, whose existence would also suggest a common mechanism for ALS and fALS. The mechanism here proposed for SOD1 mutant oligomerization is absolutely general and it provides a common unique picture for the behaviors of the many SOD1 mutants, of different nature and distributed all over the protein.